Vieira Luisane Maria Falci, Emery Eduardo, Andriolo Adagmar
Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil.
Immunology Committee, Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil.
Sao Paulo Med J. 2020 Jun;138(3):259-266. doi: 10.1590/1516-3180.2020.0240.14052020. Epub 2020 Jun 22.
COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have the ability to infect virtually all major groups of animals and, eventually, can infect humans. SARS-CoV-2 is the third coronavirus to cross the species barrier and infect humans. This virus was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019. Its entire genome is inscribed on a single strand of ribonucleic acid. Some proteins present on the surface of the virus act as facilitators for its entry into host cells, while others, apparently, are related to its pathogenesis. Coronaviruses are responsible for respiratory infections in humans and some animals. The infection is often mild to moderate in intensity, but some coronaviruses may cause serious illnesses, such as severe acute respiratory syndrome (SARS), which occurred in 2002, and the Middle East respiratory syndrome (MERS). Coronaviruses can activate an excessive and unregulated immune response, which may promote SARS development. Although the lungs are one of the target organs, the hypoxia mechanism is systemic and other organs begin to suffer both through lack of oxygen and through deregulation of inflammation control mechanisms.
2019冠状病毒病(COVID-19)是一种由新型冠状病毒引起的传染病,该病毒与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关。冠状病毒科是一个大家族,已知其中至少有七个成员会引发人类呼吸道疾病。冠状病毒几乎能够感染所有主要动物群体,并最终感染人类。SARS-CoV-2是第三种跨越物种屏障并感染人类的冠状病毒。2019年12月,在中国湖北省武汉市爆发的肺炎病例中发现了这种病毒。其整个基因组由单链核糖核酸构成。病毒表面存在的一些蛋白质充当其进入宿主细胞的促进因子,而其他一些蛋白质显然与其发病机制有关。冠状病毒会引发人类和一些动物的呼吸道感染。感染强度通常为轻度至中度,但一些冠状病毒可能会导致严重疾病,如2002年出现的严重急性呼吸综合征(SARS)以及中东呼吸综合征(MERS)。冠状病毒可激活过度且不受控制的免疫反应,这可能会促使SARS病情发展。尽管肺部是靶器官之一,但缺氧机制是全身性的,其他器官也会因缺氧和炎症控制机制失调而开始受损。